tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for Unicycive Therapeutics Amid Regulatory and Financial Optimism
PremiumRatingsBuy Rating for Unicycive Therapeutics Amid Regulatory and Financial Optimism
21d ago
Unicycive receives CRL for oxylanthanum carbonate NDA for hyperphosphatemia
Premium
The Fly
Unicycive receives CRL for oxylanthanum carbonate NDA for hyperphosphatemia
21d ago
Unicycive Therapeutics sees cash runway into 2H26
Premium
The Fly
Unicycive Therapeutics sees cash runway into 2H26
21d ago
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Tuesday’s Biggest Stock Market Stories
1M ago
Buy Rating for Unicycive Therapeutics: Strong Market Potential Despite Vendor Compliance Issue
Premium
Ratings
Buy Rating for Unicycive Therapeutics: Strong Market Potential Despite Vendor Compliance Issue
1M ago
Unicycive Therapeutics Faces FDA Compliance Delay
Premium
Company Announcements
Unicycive Therapeutics Faces FDA Compliance Delay
1M ago
Unicycive Therapeutics Updates Annual Meeting Time
PremiumCompany AnnouncementsUnicycive Therapeutics Updates Annual Meeting Time
2M ago
Unicycive Therapeutics announces time change for FY25 annual meeting
Premium
The Fly
Unicycive Therapeutics announces time change for FY25 annual meeting
2M ago
Buy Rating for Unicycive Therapeutics Driven by Strategic Positioning and Upcoming Regulatory Milestones
Premium
Ratings
Buy Rating for Unicycive Therapeutics Driven by Strategic Positioning and Upcoming Regulatory Milestones
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100